Caldan Therapeutics' Series A Round

Caldan Therapeutics raised a round of funding on November 04, 2015.

Caldan Therapeutics is focused on the development of therapeutics targeting free fatty acid receptors for T2 diabetes and other potential indications.…

Articles about Caldan Therapeutics' Series A Round: